U.S. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Market Research: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030 [...
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
Manufacturing: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030" report from Plunkett Research Ltd has been added to ResearchAndMarkets.com's offering. The report contains vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. The U.S. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry is projected to reach $20.24 billion by 2030. This research includes Average EBITDA, Operating Ratios and Sales per Employee. This Report Features: Historical data Revenue forecasts, growth rates and CAGR Operating ratios Complete data for benchmarking a company to its industry and to specific leading companies Benchmarking this industry to all U.S. industries Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Pages: Statistical Tables Provided: Charts Provided: Key Data
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna Stock Down 39% in Three Months: Buy the Dip or Wait? [Yahoo! Finance]Yahoo! Finance
- Moderna, Inc. (NASDAQ: MRNA) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.MarketBeat
- Moderna, Inc. (NASDAQ: MRNA) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $41.00 price target on the stock.MarketBeat
- Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at JPMorgan Chase & Co. from $59.00 to $45.00. They now have an "underweight" rating on the stock.MarketBeat
- Moderna, Inc. (MRNA): An Oversold Healthcare Stock to Invest In Now [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 11/7/24 - Beat
MRNA
Sec Filings
- 12/10/24 - Form 4
- 12/9/24 - Form 144
- 12/6/24 - Form 4
- MRNA's page on the SEC website